Mayne Pharma Group Ltd
(ASX:MYX)
A$
2.57
+0.18 (+7.53%)
Market Cap: 194.18 Mil
Enterprise Value: 166.94 Mil
PE Ratio: 0
PB Ratio: 0.58
GF Score: 51/100 Half Year 2021 Mayne Pharma Group Ltd Earnings Presentation Transcript
Feb 23, 2021 / 10:00PM GMT
Release Date Price:
A$6.2
Operator;Scott Anthony Richards
Mayne Pharma Group Limited - MD, CEO &
Good day, and welcome to the Mayne Pharma Group Limited Results Half Year Call. At this time, I would like to turn the conference over to CEO, Mr. Scott Richards. Please go ahead, sir.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot